ET-1 is also associated with inflammation, microglial activation, BBB breakdown, and likely contributes to the neuroinflammatory process and ensuing neurocognitive impairment observed in CM [10, 13–16]. This evidence concerns the gene EDN1 and cutaneous mastocytosis.